Skip To Main Content
Chigusa Morizane on Muck Rack

Chigusa Morizane

As seen in: Nature, Wiley Online Library, Frontiers, JAMA Oncology, Annals of Oncology, The Lancet, Future Medicine
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Chigusa

Contact Chigusa, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Survival outcomes with matched targeted therapy in advanced biliary tract cancer: a large global cohort analysis

|
By Binbin Zheng-Lin, Taro Shibuki, Heidi E. Kosiorek, Oluseyi Abidoye, Cody Eslinger, Yasuyuki Kawamoto, Ryne C. Ramaker, Shinji Itoh, Tadayoshi Hashimoto, Takao Fujisawa, Mitsuho Imai, Angelo Pirozzi, Celine Hoyek, Mohamad B. Sonbol, Christina Wu, Nguyen Tran, Hani M Babiker, Lewis Roberts, Ashley Moyer, Yoshiaki Nakamura, Hideaki Bando, Takayuki Yoshino, Makoto Ueno, Chigusa Morizane, Daniel Ahn, Mitesh J. Borad, John Strickler, Masafumi Ikeda, Tanios S Bekaii-Saab, Madhuri Gottam
| Nature Verified
Abstract The prognosis of advanced biliary tract cancer remains poor despite up to 40% of tumors harboring actionable molecular alterations. This international collaborative study from Mayo Clinic, Duke Cancer Institute, National Cancer Center East (Japan), and the SCRUM-Japan GOZILA/MONSTAR-SCREEN projects evaluated clinical outcomes in 1049 patients with advanced BTC based on tumor molecular profiling and matched treatment selection.
Open in Who Shared Issue with article?

Epidemiology and Outcomes of Retroperitoneal Sarcoma: An Analysis of the Population‐Based Cancer Registry in Japan 2016-2019

|
By Koichi Ogura, Chigusa Morizane, Tomoyuki Satake, Toshiyuki Takemori
| Wiley Online Library Verified
Conflicts of Interest The authors declare no conflicts of interest. References 1, , , and , “Lessons Learned From the Study of 10,000 Patients With Soft Tissue Sarcoma,” Annals of Surgery 260, no. 3 (2014): 416–422; discussion 421-2. 2, , , , , and , “Outcomes for Soft-Tissue Sarcoma in 8249 Cases From a Large State Cancer Registry,” Journal of Surgical Research 141, no. 1 (2007): 105–114.
Open in Who Shared Issue with article?

Multicenter observational study to characterize fibroblast growth factor receptor 2 fusions or rearrangements in patients with advanced/metastatic cholangiocarcinoma

|
By Tomoyuki Satake, Chigusa Morizane, Hiroyuki Isayama, Akio Katanuma
| Wiley Online Library Verified
CI confidence interval ECOG Eastern Cooperative Oncology Group FGF fibroblast growth factor FGFR fibroblast growth factor receptor FISH fluorescence in situ hybridization HBV hepatitis B virus HCV hepatitis C virus ICC intrahepatic cholangiocarcinoma NGS next generation sequencing PFS progression-free survival PHC perihilar cholangiocarcinoma INTRODUCTION Cholangiocarcinoma is the second most common liver cancer globally,1 and its incidence is especially high in Asian countries.2 It is a...
Open in Who Shared Issue with article?
See all 12 articles